(Total Views: 311)
Posted On: 04/12/2019 4:41:41 PM
Post# of 149014
I wanted to see if a thumbs up would change the score, but looks like you are stuck at 2 thumbs down still!
While I agree that the 10-Q is a bit misleading if in fact they do begin the GvHD trial, most of the 'Clinical Trial Updates' are not forward looking statements. i.e. they have announced publicly (via video) that they will be incorporating the CCR5 density test for the mono pivotal trial, but they don't even mention the pivotal trail in this section. They do mention the TNBC is expected to begin in 2Q2019 and the 8 pre-clinical cancer trials that were recently initiated, but they also did an official PR on both of these.....which they have not done with mono pivotal or GvHD.
FWIW, I take the 10-Q to only address those things that have been officially announced and not forward looking.
While I agree that the 10-Q is a bit misleading if in fact they do begin the GvHD trial, most of the 'Clinical Trial Updates' are not forward looking statements. i.e. they have announced publicly (via video) that they will be incorporating the CCR5 density test for the mono pivotal trial, but they don't even mention the pivotal trail in this section. They do mention the TNBC is expected to begin in 2Q2019 and the 8 pre-clinical cancer trials that were recently initiated, but they also did an official PR on both of these.....which they have not done with mono pivotal or GvHD.
FWIW, I take the 10-Q to only address those things that have been officially announced and not forward looking.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
